Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
287
datasets available to search
ShareScore release 0.9.0
Dataset results
287 results for “respiratory syncytial virus”
Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines
ClinicalTrials.gov study NCT01905215. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults
ClinicalTrials.gov study NCT04227210. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic
ClinicalTrials.gov study NCT04944160. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessing the Burden of Respiratory Syncytial Virus (RSV)
ClinicalTrials.gov study NCT07015255. IPD Sharing: NO. Countries: 1. Publications: 8.
Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to
ClinicalTrials.gov study NCT05687279. IPD Sharing: YES. Countries: 2. Publications: 0.
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
ClinicalTrials.gov study NCT01459198. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
ClinicalTrials.gov study NCT01140048. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age
ClinicalTrials.gov study NCT02948127. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
ClinicalTrials.gov study NCT01893554. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
ClinicalTrials.gov study NCT01852266. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections
ClinicalTrials.gov study NCT02133092. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower R
ClinicalTrials.gov study NCT05590403. IPD Sharing: YES. Countries: 0. Publications: 2.
Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
ClinicalTrials.gov study NCT00420966. IPD Sharing: Not stated. Countries: 1. Publications: 17.
A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older
ClinicalTrials.gov study NCT04354480. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as No
ClinicalTrials.gov study NCT03916185. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
ClinicalTrials.gov study NCT00658086. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (
ClinicalTrials.gov study NCT05242432. IPD Sharing: YES. Countries: 1. Publications: 1.
Immune Response to Respiratory Syncytial Virus (RSV) in Health Care Workers
ClinicalTrials.gov study NCT01563692. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
ClinicalTrials.gov study NCT02237209. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine
ClinicalTrials.gov study NCT01290419. IPD Sharing: Not stated. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.